We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

11 hedge funds and large institutions have $816K invested in Aethlon Medical in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $431K → $816K (+$385K)

0.09% more ownership

Funds ownership: 2.65% → 2.74% (+0.09%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$86.9K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$80.2K
3
CCP
Cardan Capital Partners
Colorado
+$26.7K
4
SSA
Schonfeld Strategic Advisors
New York
+$26.7K
5
UBS Group
UBS Group
Switzerland
+$6.68K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$114K
2
Renaissance Technologies
Renaissance Technologies
New York
-$37K
3
AGM
Alpine Global Management
New York
-$34K

AEMD Hedge Fund Activity: Q4 2020 in Review

11 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2020, worth a combined $816K — up 89% from $431K a quarter earlier.

Fund positioning in AEMD was balanced in Q4 2020: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $86.9K. The largest seller was Morgan Stanley, exiting entirely with an estimated $114K sold.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $816K of Aethlon Medical stock for Q4 2020, up 89% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q4 2020 and 3 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q4 2020 was Geode Capital Management, an estimated $86.9K added.
  • The largest Aethlon Medical seller in Q4 2020 was Morgan Stanley, an estimated $114K sold.

Based on aggregated 13F filings for Q4 2020.